170 related articles for article (PubMed ID: 9230146)
21. Antianginal effects of intravenous nitroglycerin over 24 hours.
Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
[TBL] [Abstract][Full Text] [Related]
22. Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity.
Hébert D; Lam JY
J Am Coll Cardiol; 2000 Dec; 36(7):2311-6. PubMed ID: 11127478
[TBL] [Abstract][Full Text] [Related]
23. Comparable effects of intravenous nitroglycerin and intravenous nitroprusside in acute ischemia.
Breisblatt WM; Navratil DL; Burns MJ; Spaccavento LJ
Am Heart J; 1988 Aug; 116(2 Pt 1):465-72. PubMed ID: 3135734
[TBL] [Abstract][Full Text] [Related]
24. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
Kośmicki MA; Szwed H; Sadowski Z
Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
[TBL] [Abstract][Full Text] [Related]
25. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
[TBL] [Abstract][Full Text] [Related]
26. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
Henry PJ; Horowitz JD; Louis WJ
J Pharmacol Exp Ther; 1989 Feb; 248(2):762-8. PubMed ID: 2563771
[TBL] [Abstract][Full Text] [Related]
27. Antianginal effects of nitroglycerin patches.
Reichek N; Priest C; Zimrin D; Chandler T; Sutton MS
Am J Cardiol; 1984 Jul; 54(1):1-7. PubMed ID: 6430053
[TBL] [Abstract][Full Text] [Related]
28. Prazosin potentiates the acute hypotensive effects of nitroglycerin but does not attenuate nitrate tolerance in normal conscious rats.
Wang EQ; Fung HL
J Cardiovasc Pharmacol; 2004 Mar; 43(3):341-6. PubMed ID: 15076216
[TBL] [Abstract][Full Text] [Related]
29. Long-term use of short- and long-acting nitrates in stable angina pectoris.
Kosmicki MA
Curr Clin Pharmacol; 2009 May; 4(2):132-41. PubMed ID: 19442078
[TBL] [Abstract][Full Text] [Related]
30. [Development of tolerance in continuous nitroglycerin infusion].
Niestegge H; Cordes G; Blümchen G
Herz; 1989 Feb; 14(1):66-70. PubMed ID: 2493413
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.
Flaherty JT
Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161
[TBL] [Abstract][Full Text] [Related]
33. Nitrate therapy for angina pectoris. Current concepts about mechanism of action and evaluation of currently available preparations.
Corwin S; Reiffel JA
Arch Intern Med; 1985 Mar; 145(3):538-43. PubMed ID: 3919668
[TBL] [Abstract][Full Text] [Related]
34. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
[TBL] [Abstract][Full Text] [Related]
35. [Effects of prolonged-action nitrates on platelet aggregation and prostaglandin formation].
Kirichenko LL; Masenko VP; Evdokimova AG; Iunusov MA
Kardiologiia; 1992 Apr; 32(4):8-10. PubMed ID: 1405245
[TBL] [Abstract][Full Text] [Related]
36. Two possible mechanisms underlying nitrate tolerance in monkey coronary arteries.
Omura T; Matsumoto T; Nakae I; Takahashi M; Kinoshita M
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):259-65. PubMed ID: 11251637
[TBL] [Abstract][Full Text] [Related]
37. Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris.
Lacoste LL; Théroux P; Lidón RM; Colucci R; Lam JY
Am J Cardiol; 1994 Jun; 73(15):1058-62. PubMed ID: 8198030
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
[TBL] [Abstract][Full Text] [Related]
39. Antiplatelet effects of a novel antianginal agent, nicorandil.
Jaraki O; Strauss WE; Francis S; Loscalzo J; Stamler JS
J Cardiovasc Pharmacol; 1994 Jan; 23(1):24-30. PubMed ID: 7511731
[TBL] [Abstract][Full Text] [Related]
40. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
Dalal JJ; Parker JO
Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
